YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
16.00
+1.75 (12.28%)
At close: Sep 26, 2025, 4:00 PM EDT
16.38
+0.38 (2.37%)
After-hours: Sep 26, 2025, 7:45 PM EDT
12.28% (1D)
| Market Cap | 1.13B |
| Revenue (ttm) | 510,360 |
| Net Income (ttm) | -1.41M |
| Shares Out | 70.32M |
| EPS (ttm) | -1.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 355,043 |
| Open | 13.50 |
| Previous Close | 14.25 |
| Day's Range | 12.90 - 20.88 |
| 52-Week Range | 5.30 - 25.00 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About YDES
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. [Read more]
Industry Biotechnology
Sector Healthcare
Founded 2013
Country Taiwan
Stock Exchange NASDAQ
Ticker Symbol YDES
Website https://www.ydesgroup.com
Financial Performance
Financial StatementsNews
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the N...
4 weeks ago - PRNewsWire